EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]


EQS Preliminary announcement financial reports: PharmaSGP Holding SE / Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

21.09.2023 / 15:33 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Werbung


PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: September 28, 2023
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: September 28, 2023
Address: https://ir.pharmasgp.com/en/#FinancialReports


21.09.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 1
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com

 
End of News EQS News Service

Werbung

1731665  21.09.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1731665&application_name=news&site_id=smarthouse

Aktuelle PharmaSGP Aktie News

Werbung

PharmaSGP Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für PharmaSGP nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.